feedback

Course Director

Susan Blumel, RN, BSN
Susan Blumel, RN, BSN

Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska

Faculty

Colleen Callahan
Colleen Callahan, RN, MSN, CRNP

The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Gina Martin
Gina Martin, BSN, RN

Winship Cancer Institute of Emory University
Atlanta, Georgia

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CNE
Credit Amount:1.5 Credits
Release Date:2019-May-24
Expiration Date:2020-May-23
Estimated Time for Completion:90 minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

Chimeric antigen receptor (CAR)-T cell therapy has recently emerged as an effective strategy for the management of multiple hematologic malignancies and offers hope for patients in leukemia, lymphoma, and myeloma settings. Oncology nurse professionals have a central role within the hematology-oncology team in guiding patients through their treatment continuum with this innovative drug class. In this activity, based on a recent live symposium, an expert panel takes a deep dive into the science behind adoptive immunotherapy with CAR-T cells. They provide guidance on best nursing practices to effectively apply lymphodepletion regimens, safely administer CAR-T cell therapy, appropriately monitor for and manage unique CAR-T cell–related toxicities, educate and counsel patients on expectations from therapy throughout the treatment protocol, as well as collaborate and communicate with the team members to optimize benefit from this novel treatment approach in a diverse range of hematologic malignancies.

Upon completion of this activity, participants will be able to:
  • Discuss the latest science, including rationale, recent evidence, and ongoing clinical research, on adoptive immunotherapy with chimeric antigen receptor (CAR)-T cells in a range of hematologic malignancies
  • Implement practical interventions for monitoring and managing the unique safety issues associated with the use of different CAR-T cell approaches
  • Employ effective strategies to educate, support, and counsel patients with leukemia, lymphoma, and myeloma receiving CAR-T cell therapy, including in the context of a clinical trial, to optimize benefit and overall care

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and other clinicians involved in the management of patients with leukemia, lymphoma, and multiple myeloma.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CNE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: May 24, 2019 - May 23, 2020
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Other PVI associates who are in a position to have control over the content of this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CNE activity during the past 12 months.

The associates of the Medical Learning Institute, Inc., the accredited provider for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CNE activity during the past 12 months.

Course Director and Moderator

Susan Blumel, RN, BSN
Lymphoma Clinical Research Nurse Coordinator
Fred & Pamela Buffett Cancer Center
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Susan Blumel, RN, BSN, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Evidera; Juno Therapeutics; and Kite Pharma, Inc.

Susan Blumel, RN, BSN, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: different CAR-T cell products in a range of hematologic malignancies.

Faculty

Colleen Callahan, RN, MSN, CRNP
Nurse Practitioner
Cancer Immunotherapy Team, Division of Oncology
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Colleen Callahan, RN, MSN, CRNP, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Novartis Pharmaceuticals Corporation.

Colleen Callahan, RN, MSN, CRNP, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: different CAR-T cell products in a range of hematologic malignancies.

Gina Martin, BSN, RN
Clinical Research Nurse II
Clinical Trials Office, Cellular Therapy
Winship Cancer Institute of Emory University
Atlanta, Georgia

Gina Martin, BSN, RN, has no financial interests/relationships or affiliations in relation to this activity.

Gina Martin, BSN, RN, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: different CAR-T cell products in a range of hematologic malignancies.

Content Reviewers

Tracy L. Greene, MSN, RN, FNP-C, Lead Nurse Planner, has no financial interests/relationships or affiliations in relation to this activity.

Pamela Ash, RN, MSN, CBCN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Aarati Ranganathan, PhD
PVI, PeerView Institute for Medical Education

Aarati Ranganathan, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CNE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit, and Support

Nurses

Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Successful completion of this continuing nursing education activity will be awarded 1.5 contact hour(s).

Providership


This CNE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CNE Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2019, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.